.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Novartis
Farmers Insurance
Cerilliant
McKesson
Teva
Daiichi Sankyo
Deloitte
Cipla
Moodys

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020987

« Back to Dashboard

NDA 020987 describes PROTONIX, which is a drug marketed by Wyeth Pharms Inc and is included in three NDAs. It is available from twelve suppliers. There are eight patents protecting this drug and one Paragraph IV challenge. Additional details are available on the PROTONIX profile page.

The generic ingredient in PROTONIX is pantoprazole sodium. There are forty-seven drug master file entries for this compound. Sixty-one suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.

Summary for 020987

Tradename:1
Applicant:1
Ingredient:1
Patents:1
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020987

Mechanism of ActionProton Pump Inhibitors

Suppliers and Packaging for NDA: 020987

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROTONIX pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 020987 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0008-0841 0008-0841-81 90 TABLET, DELAYED RELEASE in 1 BOTTLE (0008-0841-81)
PROTONIX pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 020987 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0008-0843 0008-0843-81 90 TABLET, DELAYED RELEASE in 1 BOTTLE (0008-0843-81)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, DELAYED RELEASE;ORALStrengthEQ 40MG BASE
Approval Date:Feb 2, 2000TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Jun 7, 2017Product Flag?Substance Flag?Delist Request?Y

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, DELAYED RELEASE;ORALStrengthEQ 20MG BASE
Approval Date:Jun 12, 2001TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Jun 7, 2017Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 020987

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms IncPROTONIXpantoprazole sodiumTABLET, DELAYED RELEASE;ORAL020987-001Feb 2, 2000► Subscribe► Subscribe
Wyeth Pharms IncPROTONIXpantoprazole sodiumTABLET, DELAYED RELEASE;ORAL020987-002Jun 12, 2001► Subscribe► Subscribe
Wyeth Pharms IncPROTONIXpantoprazole sodiumTABLET, DELAYED RELEASE;ORAL020987-002Jun 12, 2001► Subscribe► Subscribe
Wyeth Pharms IncPROTONIXpantoprazole sodiumTABLET, DELAYED RELEASE;ORAL020987-001Feb 2, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Deloitte
Harvard Business School
Federal Trade Commission
Cipla
Boehringer Ingelheim
Teva
US Army
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot